Neo Ivy Capital Management - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q1 2022$156,000
+81.4%
6,212
+162.7%
0.14%
+14.6%
Q4 2021$86,000
-58.5%
2,365
-29.2%
0.12%
-46.8%
Q4 2020$207,000
+6800.0%
3,340
+4885.1%
0.23%
+7600.0%
Q3 2020$3,000
-98.0%
67
-98.2%
0.00%
-98.7%
Q1 2020$147,0003,6470.24%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 276,400$4,726,0001.88%
TANG CAPITAL MANAGEMENT LLC 500,000$8,550,0001.78%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 94,300$7,131,0001.72%
Integral Health Asset Management, LLC 300,000$5,130,0001.48%
SILVERARC CAPITAL MANAGEMENT, LLC 139,200$2,380,0001.35%
MANGROVE PARTNERS IM, LLC 686,300$11,736,0001.05%
Ikarian Capital, LLC 600,000$10,261,0000.72%
Ikarian Capital, LLC 600,000$10,260,0000.72%
Sofinnova Investments, Inc. 517,708$8,853,0000.52%
Birchview Capital, LP 25,000$428,0000.29%
View complete list of CHEMOCENTRYX INC shareholders